SVRA Message Board Post 10684084 | Savara Inc.
home / stock / svra / svra message board
michaelmansuniv
(investorshangout)
Posted on: Dec/30/2019 21:09:04
Source: investorshangout
https://investorshangout.com/post/view?id=5630735
znewcar1: SVRA 183% v53M c4.91 f41M H5.2 gapped up 4.6 S@3.25 then EOD push to
News, Short Squeeze, Breakout and More Instantly...
-
Pivotal Phase 3 IMPALA-2 Trial Remains On-track, Top Line Results Expected by End of 2Q 2024 48-week placebo-controlled trial is evaluating molgramostim nebulizer solution (molgramostim), a novel inhaled biologic, for the treatment of autoimmune Pulmonary Alveolar Proteinosis (aPAP), a ra...
-
Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will participate in a fireside chat at the Citizens JMP Life Science Conference on May 14, 2024 at 6:00am PT/9:00am ET. A live webcast of the fir...
-
Savara’s Partner, Trillium Health LLC, to Present Data on the Laboratory Blood Test for Diagnosing aPAP Company to Host Industry Theater on Pulmonary Alveolar Proteinosis (PAP) with Two World-Renowned Experts Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage ...